2018.04.10
FY02/2018 Q4 Results Earnings Release Presentation
2018.03.28PDF( 67KB)
Notice of Revision of Financial Forecast
2018.02.27PDF(195KB)
Notification of the results of Phase III clinical study of HP-3000 in Japan (a transdermal drug for the treatment of Parkinsonfs disease)
2018.02.08PDF(194KB)
Announcement of Establishment of New Company
2018.02.06PDF(276KB)
Hisamitsu Pharmaceutical, Becomes an Official Partner (External Pain Relief Products) of the Olympic and Paralympic Games Tokyo 2020!